Iodine-125 Brachytherapy for Uveal Melanoma: A Systematic Review of Radiation Dose
Ocular Oncology and Pathology · 2017 · 3 (3) · 193-198
DOI: 10.1159/000455872 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ocular Oncology and Pathology, online erschienen am 08.02.2017. Verfasst von Jose J Echegaray und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Puerto Rico School of Medicine, San Juan, Puerto Rico, USA. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aim
To investigate whether lower radiation doses may yield similar outcome measures to those from the COMS trial.
Methods
A literature review of English language articles was performed using the PubMed database of the U.S. National Library of Medicine and the Cochrane Central Register of Controlled Trials using the following keywords: uveal melanoma, choroidal melanoma, primary uveal malignant melanoma, iodine-125 brachytherapy, local recurrence, local treatment failure, and local tumor control. The relationships between study local recurrence rate and median dosage were tested by linear regression, with each study weighted by the number of patients included.
Results
Fifteen retrospective and prospective studies were selected for systematic review (2,662 patients). Ranges of reported mean or median radiation dose to tumor apex were 62.5-104.0 Gy. Local recurrence rates ranged from 0 to 24%. A 1.0-Gy increase in the average study dose was associated with a 0.14% decrease in local recurrence rate, which was not statistically significant (p value 0.336).
Conclusion
The gold standard empirically derived 85.0-Gy radiation dose for the treatment of uveal melanoma could be tested in a randomized study.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, University of Puerto Rico School of Medicine, San Juan, Puerto Rico, USA.
- Department of Ophthalmology, Medical University Innsbruck, Innsbruck, Austria.
- Department of Ophthalmic Oncology, Case Western Reserve University, School of Medicine, Cleveland, Ohio, USA.
- Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Zitieren
APA
Echegaray, J. J., Bechrakis, N. E., Singh, N., Bellerive, C., & Singh, A. D. (2017). Iodine-125 Brachytherapy for Uveal Melanoma: A Systematic Review of Radiation Dose. Ocular Oncology and Pathology, 3(3), 193-198. https://doi.org/10.1159/000455872
Vancouver
Echegaray JJ, Bechrakis NE, Singh N, Bellerive C, Singh AD. Iodine-125 Brachytherapy for Uveal Melanoma: A Systematic Review of Radiation Dose. Ocular Oncology and Pathology. 2017;3(3):193-198. doi:10.1159/000455872
BibTeX
@article{Echegaray2017,
author = {Echegaray, Jose J and Bechrakis, Nikolaos E and Singh, Nakul and Bellerive, Claudine and Singh, Arun D},
title = {Iodine-125 Brachytherapy for Uveal Melanoma: A Systematic Review of Radiation Dose},
journal = {Ocular Oncology and Pathology},
year = {2017},
volume = {3},
number = {3},
pages = {193--198},
doi = {10.1159/000455872}
}
EUVIMED